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The purpose of this thesis is to investigate the link between advanced paternal ages 
(APA) (i.e., APA ≥ 35 years and APA ≥ 50 years) and genetic diseases and congenital 
anomalies. Currently, the relationship between both advanced paternal ages and genetic diseases 
and congenital anomalies remains unclear. There is room for improvement, however, to 
investigate systematically the relationship between specific congenital anomalies in newborns 
and advanced paternal ages. More recently, the link between advanced paternal age (as opposed 
to existing studies analyzing advanced maternal age alone) and genetic diseases has been 
recognized by researchers, epidemiologists, and various health experts. Thus, this study serves to 
examine the effect of advanced paternal ages on the likelihood of birth defects using a new 
dataset intended to discover those relationships. 
I create three different datasets and utilize 12 statistical models to analyze the relationship 
between advanced paternal ages (APA ≥ 35 years and APA ≥ 50 years) (while including 
advanced maternal age or AMA [AMA ≥ 35 years]) and genetic diseases and congenital 
anomalies. I focus on Down syndrome, cleft lip with or without cleft palate, and 
meningocele/spina bifida and explore the relationship between both advanced parental ages. I 
explore whether (a) the advanced paternal ages and (b) the advanced maternal age increase the 
likelihood of newborn reproductive defects: (a) Down syndrome, (b) cleft lip with or without 
cleft palate, and (c) meningocele/spina bifida. This study includes all U.S. births between 2016 
and 2019 using the CDC Natality Registry1 database (2020). I perform the analyses using logistic 
 
1 Collection of data for all variables used in this research are obtained with full permission from: United States 
Department of Health and Human Services (US DHHS), Centers for Disease Control and Prevention” "(CDC), 
National Center for Health Statistics (NCHS), Division of Vital Statistics, Natality public-use data 2016-2019, on 
CDC" WONDER Online Database, October 2020. Accessed at http://wonder.cdc.gov/natality-expanded-
iv 
 
regression models (to estimate odds ratios) that provide explanations of the relationship between 
each birth defect and advanced paternal ages. Analysis results suggest that advanced paternal 
ages (APA ≥ 35 years and APA ≥ 50 years) are positively associated with Down syndrome, 
whereas advanced paternal age (APA ≥ 35 years) is negatively associated with cleft lip with or 
without cleft palate. The results from the advanced paternal ages models do not suggest any 
causal relationship/effect on spina bifida. The results of this study are expected to offer some 
insight of the following reproductive defects: (a) Down syndrome, (b) cleft lip with or without 
cleft palate, and (c) meningocele/spina bifida. 
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In some parts of the world, there are some views that women’s suitable [childbearing] 
age is about ten years less than men’s age (Allendorf et al., 2017). The “gender gap in marital 
timing2” or biological clock may be influenced by societal taboos and myths on fertility and 
attributing reproductive defects to the mother’s age only (Ibid., 2017). Medical studies on high-
risk pregnancies in aging mothers (AMA ≥ 35 years) have been linked to an aged reproductive 
system and an aged body (Lampinen et al., 2009). As the mother ages, the integrity of the ova 
deteriorates, which may be linked to both decreased fertility and higher risk of chromosomal 
abnormalities (Heffner, 2021). Consequently, many studies have focused on the connection 
between advanced maternal age (AMA ≥ 35 years) and genetic diseases to support the theory on 
aging female fertility and reproductive abnormalities (Ibid., 2021). However, the identified 
advanced maternal age only offers half the answer to reproductive anomalies (Cnattingius et al., 
1992; Bianco et al., 1996; Dollberg et al., 1996; Breart et al., 1997; Jolly et al., 2000; Hollier et 
al., 2000; Reefhuis et al., 2004). Thus, the potential reproductive anomalies cases relate to the 
question I focus on in this thesis. Do the advanced paternal ages (APA ≥ 35 years and APA ≥ 50 
years) and advanced maternal age (AMA ≥ 35 years) contribute to genetic diseases and 
congenital anomalies in newborns?   
Studies suggest advanced maternal age is viewed to be linked with a higher prevalence of 
chronic medical anomalies (Lampinen et al., 2009; Carolan and Nelson, 2007). Essentially, the 
 
2 On average, the suitable age range for a woman to marry is 20 to 25, whereas the man’s acceptable age range is 
between 23 and 30 (Allendorf et al., 2017). 
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literature often studies the relationship between female age and birth anomalies in newborn 
children, and the alternate relationship between the male’s advanced age on reproductive 
abnormalities remains scarce and unclear (Conti and Eisenberg, 2016). There is room for 
developing this topic, however, to investigate both paternal ages and maternal age on specific 
anomalies in infants. More recently, the link between advanced paternal ages and genetic 
diseases has become a topic of interest among researchers, epidemiologists3, and various health 
experts. Thus, this study serves to explore the effect of advanced paternal ages on the likelihood 
of birth defects4 such as genetic diseases and congenital anomalies.  
The Main Argument 
Birth defects, which may manifest their signs at birth or later in the affected individual’s 
life, may be genetic in nature. From the onset of human reproduction, “abnormal genes in the 
reproductive cells of one or both parents, [among various predictors] cause[s] mutations” 
(Kalumuck, 2019). In 1912, Weinberg suggested that if a study were intended to analyze more 
directly the link between mutations and last-born children, we could better understand the 
susceptibility to dwarfism (known as achondroplasia) (Crow, 2000: 40). Weinberg’s (1912) 
achondroplasia trait observation established the initial conception of human genetics (Crow and 
Hardy, 1999). Weinberg’s (1912) original observation was first studied by Haldane (1947) who 
suggested the level of male mutation is approximately ten times higher than that of the female, 
which despite uncertain valuations, was substantiated in incidences of Haemophilia A5 (a genetic 
 
3 Epidemiologists practice the field of medicine that focuses on the “incidence, distribution, and possible control of 
diseases and other factors relating to health” (Lexico, 2020). 
4 “Birth defects” is also used as an alternative when referencing genetic diseases and congenital anomalies (Grewal 
et al., 2012).  
5 Becker et al., 1996. 
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deficit usually impacting males) and Hemophilia B6 (a genetic bleeding disorder)” (Crow, 2000: 
40). Advancing Weinberg’s (1912) initial theory on genetic mutations can be used to further our 
understanding of other genetic diseases regulated by biological functions.  
Based on Haldane’s (1947) study, Penrose (1955) further studied the genetic mutations 
model and suggested that paternal age may possibly be the only cause of Weinberg’s original 
1912 study (Crow, 2000: 40). Since [advanced] paternal age may be linked to genetic mutation, 
which may heighten the risk of birth defects, Penrose’s proposed ‘copy error’ theory (1955) was 
developed (Grewal et al., 2012). Penrose (1955) claimed that since male germ cells experience 
constant mitotic divisions, there may be a higher likelihood of spontaneous mutations in the male 
germ line than that of the female (Grewal et al., 2012: 387). Therefore, the higher rate of germ 
cell division or spermatogenesis in advanced paternal age relative to the female germ line (or 
oogenesis) in advanced maternal age may be associated with congenital anomalies (Materna-
Kiryluk et al., 2008). In human males, the time of spermatogenesis is between 72 - 74 days, 
which involves division of germ cells during the meiosis and mitosis phases, increasing the 
vulnerability of “cytotoxic damage” or altering the “DNA7 sequence” resulting in genetic 
mutations (Ibid., 2008: 30). By the time a male is 35 years, the spermatozoa (or motile sperm 
cells) will have undergone about “540 divisions and replications” that accumulate in the older 
father’s sperm, thus increasing the likelihood of congenital malformations (Grewal et al., 2012: 
389). Based on the literature that analyzes the link between paternal age and genetic 
abnormalities, I adopt APA ≥ 35 years as the advanced reproductive age for the father. Vogel 
 
6 Ketterling et al., 1999. Green et al., 1999. 
7 DNA is the abbreviation for Deoxyribonucleic acid, which is a molecule that consists of the biological directions 
that exclusively define the characteristics of each breed (National Human Genome Research Institute, 2020). 
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and Motulsky (1997) add that males undergo 840 spermatic replications by age of 50, potentially 
increasing the likelihood of transcription errors throughout the replication process (Penrose, 
1955). Thus, considering a higher rate of spontaneous mutations in older fathers’ sperm, I argue 
that when paternal ages are APA ≥ 35 years and APA ≥ 50 years—combined with the advanced 
maternal age of AMA ≥ 35 years—there may be a higher probability of birth defects in the 
couple’s newborn (Halvaei et al., 2020).    
Building on Penrose’s (1955) theory, epidemiologists have identified over four thousand 
“gene disorders” that are inherited, and such chromosomal abnormalities may be identified as 
numerical8 and/or structural9 (Powell-Hamilton, 2018). While science has advanced in the 
classification and categorization of chromosomal abnormalities, there is insufficient focus on 
advanced paternal age and genetic mutations. Despite the existing theory used to justify the 
possible connections between disorders in newborns and paternal age, studies remain 
unsystematic in comparing the advanced paternal ages and advanced maternal age on the effect 
of genetic diseases (Thompson, 2019).  
According to Grewal et al. (2012), some studies analyzed and suggested a positive 
relationship between APA and heart defects in newborns (Lian et al., 1986; Olshan et al., 1994; 
Yang et al., 2007; and Materna-Kiryluk et al., 2008), neural tube and upper limb defects 
(McIntosh et al., 1995), orofacial clefts (Materna-Kiryluk et al., 2008; McIntosh et al., 1995; 
Polednak, 1976; and Bille et al., 2005) and malformations in the nervous system (Kazaura et al., 
 
8 Numerical abnormalities contain an extra chromosome (i.e., Trisomy) and a missing chromosome (i.e., 
Monosomy) (Powell-Hamilton, 2018). 
9 Structural abnormalities contain anomalies whereby an entire chromosome (or parts of chromosomes) do(es) not 
properly connect with other chromosomes (i.e., Translocations) and deletions and duplications of several 
chromosomal parts (Powell-Hamilton, 2018).   
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2004). Conversely, similar studies found a negative relationship suggesting there is a higher 
likelihood of “congenital heart defects” among young paternal age (Zhan et al., 1995), “neural 
tube defects” (McIntosh et al., 1995; Kazaura et al., 2004), “anencephaly and spina bifida” 
(Yang et al., 2007; Kazaura et al., 2004), and “gastroschisis” (Yang et al., 2007; Materna-
Kiryluk et al., 2008; and Archer et al., 2007). However, these studies are inconsistent in using 
reliable sources to obtain data on birth defects, do not include the partner’s age in their analyses 
(i.e., the mother’s age), and obtain limited sample size of birth defects in their analyses (Grewal 
et al., 2012). While the said findings offer guidance concerning the advanced father’s age as a 
potential factor affecting birth defects in newborns, there are some discrepancies that are not 
accounted for in the aforementioned analyses (i.e., the female partner’s age, a larger sample, and 
observations using reliable sources). Hence, it is difficult to analyze fully the predictors of birth 
defects that manifest at birth when only one parent’s age characteristics is considered. Thus, the 
inclusion of both advanced parents’ ages may provide some explanation in the empirical study of 
advanced paternal ages and reproductive anomalies.  
Since the previous studies use Penrose’s (1955) copy error theory to analyze the link 
between APA and reproductive anomalies, I argue that when advanced paternal ages (APA ≥ 35 
years and APA ≥ 50 years) are in place, the higher rate of spontaneous mutations may increase 
the likelihood of birth defects when including the theory on advanced maternal age (AMA ≥ 35 
years) in the analyses. 
According to CDC Natality Registry report, genetic diseases that become apparent or 
detected at birth are known as congenital anomalies (2020). Accordingly, this research aims to 
take a more nuanced approach by identifying genetic diseases that manifest into congenital 
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anomalies in newborns using the CDC Natality Registry10 (2020) to analyze the link between 
APA and reproductive anomalies. In particular, this research will analyze Down syndrome, cleft 
lip with or without cleft palate, and meningocele/spina bifida11 (2020). Since these three 
congenital anomalies may appear because of idiosyncratic genetic code—a complex mechanism 
in the physiology of reproduction—this research provides additional analyses to determine a 
potential link between advanced paternal ages and the three congenital anomalies. The literature 
considers that both parents’ family history relates to some reproductive anomalies, but the 
literature that analyzes the relationship of APA, while accounting for AMA, on genetic 
abnormalities is limited at best (Powell-Hamilton, 2018). Basically, this research assumes that if 
there is an advanced maternal age effect, then there ought to be a similar structure to the 
advanced paternal age effect, such that the select congenital diseases will appear sharply for the 
higher parental age-groups (APA ≥ 35 years and APA ≥ 50 years and AMA ≥ 35 years) (Stene et 




10 Collection of data for all variables used in this research are obtained with full permission from: United States 
Department of Health and Human Services (US DHHS), Centers for Disease Control and Prevention” "(CDC), 
National Center for Health Statistics (NCHS), Division of Vital Statistics, Natality public-use data 2016-2019, on 
CDC" WONDER Online Database, October 2020. Accessed at http://wonder.cdc.gov/natality-expanded-
current.html on Jun 6, 2021, 1:24:47 PM;" United States Department of Health and Human Services (US DHHS), 
Centers for Disease Control and Prevention" "(CDC), National Center for Health Statistics (NCHS), Division of Vital 
Statistics, Natality public-use data 2016-2019, on CDC" "WONDER Online Database, October 2020. Accessed at 
http://wonder.cdc.gov/natality-expanded-current.html on Jun 6, 2021, 1:29:36 PM;” And United States 
Department of Health and Human Services (US DHHS), Centers for Disease Control and Prevention""(CDC), 
National Center for Health Statistics (NCHS), Division of Vital Statistics, Natality public-use data 2016-2019, on 
CDC" "WONDER Online Database, October 2020. Accessed at http://wonder.cdc.gov/natality-expanded-
current.html on Jun 6, 2021, 1:07:36 PM." 
11 Spina Bifida is Meningocele, which is characterized with “a sac fluid [that] comes through an opening in the 
baby’s back” (CDC, 2020). In this research, I will use “spina bifida” when discussing this reproductive anomaly. 
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Significance of Research 
 The exact cause of congenital anomalies—also called birth defects—are not known, but 
there are certain factors (e.g., advanced parental ages, “nutritional deficiencies, certain types of 
infection and other illness in the mother . . . and hereditary disorders”) that have been linked with 
a higher likelihood of such birth defects (Berkow et al., 1997: 1223). While the literature 
suggests that genetic and chromosomal factors are inherited by “one or both parents”, most 
studies analyze advanced maternal age (AMA ≥ 35 years) on the likelihood of a chromosomal 
abnormality (Ibid., 1997: 1224). Hence, the premise of this study is to account for advanced 
paternal ages (APA ≥ 35 years and APA ≥ 50 years), alongside the mother’s advanced age, on 
the propensity of genetic diseases that manifest into congenital anomalies in newborns. The need 
for this study allows for a comparable understanding using quantitative statistical methods to 
demonstrate the link between APA on Down syndrome, cleft lip with or without cleft palate, and 
spina bifida—all of which are classified under genetic diseases. It is the genetic material that 
mainly contribute to the development of congenital anomalies in infants (Stene et al., 1977). 
Thus, concentrating on the replication factor that may enhance the proclivity of mutation with 
advanced paternal age, it is plausible to hypothesize that advanced paternal ages (while including 
the advanced maternal age in the analyses) may increase the likelihood for such congenital 
anomalies (Penrose and Smith, 1966).   
My research offers three novel datasets that analyze the link between APA and three 
separate congenital anomalies (i.e., Down syndrome, cleft lip with or without cleft palate, and 
spina bifida) using the CDC Natality Registry from 2016-2019. Thus, this research advances the 
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existing literature by examining the effect of two advanced paternal ages (APA ≥ 35 years and 




Chromosomal diseases result when there is in an abnormality in one’s genetic structure 
during the fertilization process (Lobo and Zhaurova, 2008). Such genetic birth abnormalities can 
be classified into three categories: “chromosomal abnormalities (e.g., Down syndrome), single-
gene defect (e.g., sickle cell disease, cystic fibrosis, Huntington disease, muscular dystrophy, and 
Fragile X syndrome), and multifactorial influences (e.g., cleft lip and palate, spina bifida) 
whereby the mixture of genetic mutations and teratogens/environmental factors interact leading 
“to the development of multifactorial birth defects” (Ibid., 2008). In this research, I focus on 
genetic birth abnormalities classified under chromosomal abnormalities (Down syndrome) and 
multifactorial birth defects (cleft lip with or without cleft palate and spina bifida).  
Theory 
Chromosomal diseases have been linked to a complex interaction of one’s composition 
and—in some cases—environmental influencers. Down syndrome results from a chromosomal 
abnormality alone, whereas cleft lip and spina bifida may manifest from the interaction of 
genetic mutations and environmental effects leading to multifactorial influences (Lobo and 
Zhaurova, 2008). Thus, it is reasonable to argue that congenital anomalies have been traced to 
genetic mutation using the copy error mechanism to explain the manifestation of genetic birth 
abnormalities (or genetic diseases) (Penrose, 1955: 312-313). While it is not considered the only 
mechanism behind congenital anomalies in newborns, the copy error theory proposes that 
numerous “cell divisions during spermatogenesis allow for the introduction of transcription 
errors” throughout the replication process, which are later transmitted as “gene mutations” 
(Penrose, 1955: 312-313). Since Penrose’s (1955) copy error theory, researchers further 
10 
 
developed his body of research to analyze the possible relationships between birth defects and 
APA (Thompson, 2019). I utilize the copy error mechanism in the aging father to explain the 
potential relationship between advanced paternal ages and reproductive abnormalities.   
While extensive studies suggest AMA raises the likelihood of congenital anomalies, very 
few consider the effect of APA on various congenital anomalies (McIntosh et al., 1995). 
Additionally, studies that have evaluated APA on congenital anomalies have a small number of 
observations and often focus on “advanced paternal age and Down syndrome”, neglecting other 
dominant mutations at birth (McIntosh et al., 1995). Additionally, later investigations overlooked 
the mother’s age to test properly the role of both advanced paternal ages on various birth defects 
(King and Bearman, 2010; Durkin et al., 2010; King et al., 2010; Reichenberg et al., 2010). More 
recently, though, there have been a few discussions suggesting a connection between APA and 
“neonatal and pediatric disorders” but there is a lack of quantitative analyses on this observation 
(Thompson, 2019: 2; Andersen and Urhoj, 2017; Sigman, 2017). Therefore, it is important to 
include both paternal ages to properly understand the implications of the advanced paternal ages 
during reproduction. Drawing on the effect of copy error theory, I conduct separate analyses of 
the three congenital anomalies: Down Syndrome, cleft lip with or without cleft palate, and spina 








Trisomy 21 (Down syndrome), trisomy 13 (Patau syndrome), and trisomy 18 (Edwards 
syndrome) are the highest recurring birth disorders among chromosomal abnormalities (Lobo 
and Zhaurova, 2008). Down syndrome is one of the most common chromosomal abnormalities, 
which affects 1 in 800 babies, with an average of 6,000 newborns affected annually in the U.S. 
(Children’s Hospital of Philadelphia, 2020). This incurable disorder yields moderate to severe 
intellectual, physical, and neurological disabilities and concurring health issues (e.g., “heart 
defects [congenital heart disease], leukemia, and Alzheimer’s disease”) in the affected individual 
(Lobo and Zhaurova., 2008).  According to the Global Down Syndrome Foundation (Children’s 
Hospital of Philadelphia, 2020), the precise cause of the disease remains ambiguous, but research 
suggests that Down syndrome “increases with maternal age”, especially after a female is 35-
years or older (Lobo and Zhaurova, 2008). More generally, Down syndrome (identified as 
Trisomy 21) is more likely to occur from females than males but there is lack of sufficient 
evidence to exclude males in the causation of this disease (Hassold et al., 1996). Thus, it is 
reasonable to include the father’s age to determine more clearly the possible relationship 
between advanced age and chromosomal abnormalities in newborns.  
During the non-disjunction process—when the chromosomes fail to separate properly—
Down syndrome develops when three copies of chromosome12 exist rather than two 
(Dreamscape, 2020). In confirmed Down syndrome cases, non-disjunction occurs in “anaphase, 
when a pair of homologous chromosomes do not separate before being distributed into two 
 
12 The packaged arrangement of Deoxyribonucleic acid (DNA) is called chromosome (National Human Genome 
Research Institute, 2020).  
12 
 
daughter cells”, which results in cells where “one cell has two copies of a chromosome”, while 
the other cell does not have any copies (Sparkes and Crandall, 1972). According to Thompson 
(2019), it is imperative to ascertain the exposures that yield non-disjunction in oocyte 
development, which is overwhelmingly age-related, and non-disjunction in sperm development, 
whereby the paternal age effect is still ambiguous. Thus, based on Penrose’s (1955) theory, 
which suggests that gene expression13 may also stem from the [aging] male, incorporating the 
father’s age in epidemiological and/or genetic studies “may provide leads to causal factors” to 
various types of genetic disorders (Crow, 2000: 44).   
Cleft Lip 
Cleft lip with or without cleft palate (NSCL/P) affects “1 in 700 - 1,000 newborns” 
annually in the U.S. and such a congenital craniofacial defect has become increasingly common 
in newborns (Beiraghi et al., 2007). Research suggests a greater emphasis on paternal age as 
opposed to maternal age in cases related to autosomal dominant congenital diseases (e.g., cleft 
lip and palate) (Conti and Eisenberg, 2016). To ascertain this phenomenon, Vogel and 
Rathenberg (1975) and Drost and Lee (1995) explain a difference in gametogenesis between 
genders (Conti and Eisenberg, 2016). Gametogenesis is known as the process whereby cells 
experience meiosis to form gametes in the sexual reproduction to create a zygote (ThoughtCo., 
2020). In particular, every oocyte undergoes 23 chromosome replications in total (i.e., “22 germ-
cell divisions and two meiotic divisions”), but there is no DNA replication in the last meiotic 
division (Ibid., 421). Since a female is born with all oocytes (i.e., immature egg/ovum) “she will 
 
13 When instructions found in DNA are changed into a “functional product, such as protein”, it is known as the 
gene expression process (Yourgenome, 2020). 
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ever have” (Gurevich, 2020), “cell divisions [in females] are completed before birth, there is no 
increases [in DNA replication] with postnatal age” (Crow, 2000:41). This phenomenon of DNA 
replication in females, researchers propose, yields a lower likelihood of genetic mutations during 
the human reproduction stage.    
However, spermatogenesis in males is continuous throughout one’s age, thus 
“[increasing] the number of chromosome replication events” and reaching on average 840 
spermatic chromosome replication events by the age of 50 (Conti and Eisenberg, 2016: 421; 
Vogel and Motulsky, 1997; Kong et al., 2012). The continuous DNA replication processes may 
produce higher proclivities for copy error mutations, which places a potential causal relationship 
between paternal aging and genetic diseases (Conti and Eisenberg, 2016).      
Spina Bifida 
The literal meaning of spina bifida is “cleft spine,” and such a neural tube defect has 
become increasingly common in newborns affecting on average 1,500 – 2,000 out of 4 million 
newborns annually in the U.S. (National Institute of Neurological Disorders and Stroke, 2020). 
This disease is described by the partial growth of the spine, brain, and/or the layer shielding the 
spine and brain (Ibid., 2020). Experts believe spina bifida may be caused by multiple factors 
such as genetic, environmental, and nutritional agents (Ibid., 2020). Additionally, recent studies 
using birth data suggest that the likelihood of neural tube defects (NTD14s) in newborns such as 
spina bifida may be linked to AMA (i.e., ≥ 35 years) (Vieira and Castillo Taucher, 2005). Studies 
including paternal age on incidence of spina bifida are scarce although this condition is a genetic 
 
14 Deak et al., 2010. 
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disorder. Thus, this study fills the gap in the literature pertaining to the link between APA and 
genetic diseases and congenital anomalies.  
Hypotheses 
By utilizing the copy error theory (Penrose, 1955) to the advanced paternal ages-genetic 
diseases relationship, I aim to offer clarification on how advanced paternal ages may affect the 
likelihood of three separate genetic diseases in newborns. I derive three hypotheses that 
empirically test my theory: 
Hypothesis 1:  
(A) Advanced reproductive aging in both father (paternal age 35+) and mother (maternal age 
35+) are more likely to have a newborn with Down syndrome than both parents with non-
advanced reproductive aging. 
(B) The interaction between the advanced reproductive aging in both father (paternal age 
35+) and mother (maternal age 35+) are more likely to have a newborn with Down 
syndrome than both parents with non-advanced reproductive aging. 
(C) Advanced reproductive aging in both father (paternal age 50+) and mother (maternal age 
35+) are more likely to have a newborn with Down syndrome than both parents with non-
advanced reproductive aging. 
(D) The interaction between the advanced reproductive aging in both father (paternal age 
50+) and mother (maternal age 35+) are more likely to have a newborn with Down 






Hypothesis 2:  
(A) Advanced reproductive aging in both father (paternal age 35+) and mother (maternal age 
35+) are more likely to have a newborn with cleft lip with or without cleft palate than 
both parents with non-advanced reproductive aging. 
(B) The interaction between the advanced reproductive aging in both father (paternal age 
35+) and mother (maternal age 35+) are more likely to have a newborn with cleft lip with 
or without cleft palate than both parents with non-advanced reproductive aging. 
(C) Advanced reproductive aging in both father (paternal age 50+) and mother (maternal age 
35+) are more likely to have a newborn with cleft lip with or without cleft palate than 
both parents with non-advanced reproductive aging. 
(D) The interaction between the advanced reproductive aging in both father (paternal age 
50+) and mother (maternal age 35+) are more likely to have a newborn with cleft lip with 
or without cleft palate than both parents with non-advanced reproductive aging. 
Hypothesis 3:  
(A) Advanced reproductive aging in both father (paternal age 35+) and mother (maternal age 
35+) are more likely to have a newborn with spina bifida than both parents with non-
advanced reproductive aging. 
(B) The interaction between the advanced reproductive aging in both father (paternal age 
35+) and mother (maternal age 35+) are more likely to have a newborn with spina bifida 
than both parents with non-advanced reproductive aging. 
(C) Advanced reproductive aging in both father (paternal age 50+) and mother (maternal age 
35+) are more likely to have a newborn with spina bifida than both parents with non-
advanced reproductive aging. 
16 
 
(D) The interaction between the advanced reproductive aging in both father (paternal age 
50+) and mother (maternal age 35+) are more likely to have a newborn with spina bifida 





I extend the study on the link between advanced paternal ages and genetic diseases 
consisting of congenital anomalies: Down Syndrome, cleft lip with or without cleft palate, and 
spina bifida. I drew on the CDC Natality Registry (CDC, 2020) database that systematically 
compiles reported live births in the U.S., which is provided by CDC Wonder (2020). This 
research covers the period from 2016 to 2019. I eliminate all missing or unreported data from the 
overall number of observations in each model. I characterize all variables in this research as 
dichotomous. Thus, I use a different logistic regression model for each congenital anomaly.   
Dependent Variables 
I use three dependent variables to test my hypotheses. Specifically, I include genetic 
diseases that manifest into three different congenital anomalies: Down syndrome, cleft lip with 
or without cleft palate, and spina bifida. All the dependent variables in this study are 
dichotomous (0, 1) whereby I code the non-confirmed congenital anomaly as “0” and code the 
confirmed congenital anomaly as “1”. Therefore, the method of analysis is logistic regression 
using the Stata 17.0 computer program (StataCorp., 2021). I use the CDC Natality Registry 
database (2020) that consists of the United States Births Vital Statistics15 from 2016-2019 to 




15 The data available in the CDC Natality Registry are “derived from [live] birth certificates issued” from the 2016 to 
2019 years (CDC, 2020). 
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Down Syndrome:  
An observed Down syndrome case is coded as “1” if there is a confirmed case in the newborn 
and coded as “0” if not. In this model N= 3,295,210 (Table 3). 
Cleft Lip with or without Cleft Palate:  
An observed cleft lip with or without cleft palate case is coded as “1” if there is a confirmed case 
in the newborn and coded as “0” if not. In this model N= 3,296,177 (Table 5). 
Spina Bifida:  
An observed spina bifida case is coded as “1” if there is a confirmed case in the newborn and 
coded as “0” if not. In this model N= 3,296,177 (Table 7). 
Main Independent Variables 
The likelihood of reproductive anomalies among two parents may be linked to their 
advanced ages. The models in this study include the following main independent variables: (1) 
Advanced Paternal Age [APA ≥ 35 years], (2) Advanced Maternal Age [AMA ≥ 35 years], (3) 
Advanced Parental Ages (Interaction Effect of Advanced Paternal Age and Advanced Maternal 
Age [APA ≥ 35 years * AMA ≥ 35 years]). While the advanced paternal age begins at 35 years 
considering the 540 spermatic replications (Grewal et al., 2012), Vogal and Motulsky (1997) 
suggest that a male undergoes 840 spermatic replications by the age of 50 years—increasing the 
transcription errors throughout the replication process (Penrose, 1955). Thus, I include two more 
independent variables that include advanced paternal age of 50 years: (4) Advanced Paternal Age 
[APA ≥ 50 years], and (5) Advanced Parental Ages (Interaction Effect of Advanced Paternal 
Age and Advanced Maternal Age [APA ≥ 50 years * AMA ≥ 35 years]). To determine the link 
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between advanced paternal ages and the three congenital anomalies, I restrict my observations to 
include only the known/reported ages of both parents found within the Natality Registry database 
(2020) to examine the reported congenital anomaly (i.e., Down syndrome, cleft lip, and/or spina 
bifida) of each live birth from 2016-2019.  
Using the CDC Natality Registry (2020), I use observations that include disclosed age 
ranges of both partners (i.e., paternal age and maternal age) to include the father’s age range. 
Paternal age ranges are distributed into eight groups that begin from 15 years of age (with five-
year intervals): 15 – 19 years; 20 – 24 years; 25 – 29 years; 30 – 34 years; 35 – 39 years; 40 – 44 
years; 45 – 49 years; 50 – 54 years; and 55 – 98 (CDC, 2020:15). In the APA ≥ 35 years 
variable, the father’s age range grouped below 35 years [P < 35 years] is coded as “0”, and the 
father’s age range equal to or greater than 35 years [APA ≥ 35 years] is coded as “1”. In the 50 
years and above variable, the father’s age range grouped below 50 years [P < 50 years] is coded 
as “0”, and the father’s age range equal to or greater than 50 years [APA ≥ 50 years] is coded as 
“1”. The conceptualized advanced paternal ages (i.e., APA ≥ 35 years and APA ≥ 50 years) are 
both binary variables (0, 1). 
Using the CDC Natality Registry (2020), I use observations that include disclosed age 
ranges of both partners (i.e., paternal age and maternal age) to include the mother’s age range. 
Eight maternal age groups starting from 15 years of age (with five-year intervals) are identified: 
15 – 19 years; 20 – 24 years; 25 – 29 years; 30 – 34 years; 35 – 39 years; 40 – 44 years; 45 – 49 
years; and 50 – 54 years (CDC, 2020:13). Like the APA coding method, once the maternal age 
groups are identified, they are coded accordingly: if the mother’s age range is less than 35 years 
[M < 35 years], then it is coded as “0”; and if the mother’s age range is equal to or greater than 
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35 years [AMA ≥ 35 years], then it is coded as “1”. The advanced maternal age is a binary 
variable (0, 1).   
Independent Variable 1: (APA ≥ 35 years) 
1. Advanced Paternal Age 1  
Independent Variable 2: (AMA ≥ 35 years) 
2. Advanced Maternal Age  
Independent Variable 3: (APA ≥ 35 years * AMA ≥ 35 years) 
3. Interaction Effect of Advanced Paternal Age 1 and Advanced Maternal Age  
Independent Variable 4: (APA ≥ 50 years) 
4. Advanced Paternal Age 2  
Independent Variable 5: (APA ≥ 50 years * AMA ≥ 35 years)  
5. Interaction Effect of Advanced Paternal Age 2 and Advanced Maternal Age  
Control Variables  
The CDC Wonder (2020) data base includes various types of maternal factors such as 
nutritional, health, lifestyle, pregnancy complications, etc., which may influence the birth 
outcome. I use two multifactorial influences: Tobacco use during pregnancy and gestational 
diabetes (CDC, 2020). All models include these two control variables (i.e., tobacco use during 
pregnancy and gestational diabetes) to determine the propensity of Down syndrome, cleft lip 
with or without cleft palate, and spina bifida. In this study’s analyses, Table 1 includes the 12 
models. 
Tobacco Use During Pregnancy 
 One known maternal risk factor during pregnancy is the consumption of tobacco (CDC, 
2020). Tobacco consumption during pregnancy—considered as both nutritional and 
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environmental factors (or teratogenic)—increases the likelihood of reproductive anomalies in 
newborns (Zhang et al., 2017). It has been confirmed that tobacco smoke includes different 
forms of poisonous mixtures, containing cadmium, nicotine, benzo[a]pyrene, and other carbon 
monoxide, whereby such components may yield long-lasting teratogenic impacts on mammals 
(Ibid., 2012). Consequently, I predict that a pregnant mother’s consumption of tobacco increases 
the chances of Down syndrome, cleft lip with or without cleft palate, and spina bifida. According 
to CDC Wonder (2020), “tobacco use during pregnancy” reflects any form of cigarette 
consumption during pregnancy (Ibid., 2020). The consumption of cigarettes was recorded by the 
mother during the 1st, 2nd, and/or 3rd trimesters of pregnancy, ranging from 1 cigarette to 98 or 
more cigarettes consumed during said pregnancy (Ibid., 2020). Using the CDC Natality Registry 
database (2020), I include observations that reported known tobacco use by the mother during 
the observed pregnancies (coded as “1”), and mothers who did not use tobacco during pregnancy 
(coded as “0”). 
Gestational Diabetes  
 The relationship between AMA on the outcome of pregnancy have been examined 
carefully and the adverse reproductive outcomes speak volumes (Heffner, 2004).  I include 
gestational diabetes mellitus (GDM) as a control variable because there is new information to 
suggest that complications during pregnancy and reproductive outcomes may be linked to this 
factor (Zhao and Weiler, 2010; CDC, 2020). Usually during prenatal physician consultations, 
mothers are informed about the link between various levels of hyperglycemia and the severity of 
negative effects (Cho et al., 2016). Thus, including gestational diabetes as a possible 
multifactorial influence on the three congenital anomalies may improve our understanding of 
these relationships. Using the CDC Natality Registry database (2020), I include observations that 
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reported the gestational diabetes diagnosis during pregnancy (coded as “1”) and those that were 
not diagnosed with gestational diabetes during pregnancy (coded as “0”). 
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16 United States Department of Health and Human Services (US DHHS), Centers for Disease Control and 
Prevention” "(CDC), National Center for Health Statistics (NCHS), Division of Vital Statistics, Natality public-use data 
2016-2019, on CDC" WONDER Online Database, October 2020. Accessed at http://wonder.cdc.gov/natality-
expanded-current.html  on Jun 6, 2021, 1:24:47 PM."  
17 United States Department of Health and Human Services (US DHHS), Centers for Disease  
Control and Prevention" "(CDC), National Center for Health Statistics (NCHS), Division of Vital Statistics, Natality 
public-use data 2016-2019, on CDC" "WONDER Online Database, October 2020. Accessed at 
http://wonder.cdc.gov/natality-expanded-current.html   on Jun 6, 2021, 1:29:36 PM.” 
18 United States Department of Health and Human Services (US DHHS), Centers for Disease Control and 
Prevention""(CDC), National Center for Health Statistics (NCHS), Division of Vital Statistics, Natality public-use data 
2016-2019, on CDC" "WONDER Online Database, October 2020. Accessed at http://wonder.cdc.gov/natality-





According to this study, the three dependent variables Down syndrome, cleft lip with or 
without cleft palate, and spina bifida are all binary (0, 1), therefore, I use logistic regression to 
perform three separate analyses.  
The functional form of Models 1 – 4 with the dependent variable Down Syndrome is as 
follows: (Model 1) Down syndrome = f (APA 35+, AMA 35+, tobacco use, gestational diabetes).  
Model 2 includes a third term by interacting the advanced paternal age 35+ * the advanced 
maternal age 35+. (Model 2) Down syndrome = f (APA 35+, AMA 35+, [APA 35+ * AMA 
35+], tobacco use, gestational diabetes). Model 3 tests whether the advanced paternal age 50+ 
increases the likelihood of Down syndrome: (Model 3) Down syndrome = f (APA 50+, AMA 
35+, tobacco use, gestational diabetes).  And finally, Model 4 tests whether the interaction effect 
between the advanced paternal age 50+ * the advanced maternal age 35+ affects the likelihood of 
Down syndrome: (Model 4) Down syndrome = f (APA 50+, AMA 35+, [APA 50+ * AMA 35+], 
tobacco use, gestational diabetes).  
The functional form of Models 5 – 8 with Cleft Lip with or without Cleft Palate as the 
dependent variable is as follows: (Model 5) Cleft Lip = f (APA 35+, AMA 35+, tobacco use, 
gestational diabetes); (Model 6): Cleft Lip= f (APA 35+, AMA 35+, [APA 35+ * AMA 35+], 
tobacco use, gestational diabetes); (Model 7) Cleft Lip = f (APA 50+, AMA 35+, tobacco use, 
gestational diabetes); and (Model 8) Cleft Lip = f (APA 50+, AMA 35+, [APA 50+ * AMA 
35+], tobacco use, gestational diabetes).  
The functional form of Models 9 – 12 with Spina Bifida as the dependent variable is as 
follows: (Model 9) Spina Bifida = f (APA 35+, AMA 35+, tobacco use, gestational diabetes); 
(Model 10): Spina Bifida = f (APA 35+, AMA 35+, [APA 35+ * AMA 35+], tobacco use, 
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gestational diabetes); (Model 11) Spina Bifida = f (APA 50+, AMA 35+, tobacco use, gestational 
diabetes); and (Model 12) Spina Bifida = f (APA 50+, AMA 35+, [APA 50+ * AMA 35+], 
tobacco use, gestational diabetes). In the next section, I describe the results of the analyses. 
Summary Statistics 
The Summary Statistics (test statistic reports) found in Appendix A show the comparison 
of two groups (e.g., Down syndrome and APA 35+) to measure the causal relationship. For 
example, I utilize the 2 x 2 matrix that displays the distribution of confirmed Down syndrome 
cases resulting from fathers who are 35 years of age or above. The Pr value is interpreted as the 
probability (p-value) of each matrix in Appendix A. For each dependent variable, Appendix A 
provides the frequency distribution of the independent variables (i.e., Advanced Paternal Age 1 
(35+), Advanced Paternal Age 2 (50+), Advanced Maternal Age 35+, Interaction term of 
Advanced Parental Ages [APA ≥ 35 years * AMA ≥ 35 years], and Interaction term of Advanced 
Parental Ages [APA ≥ 50 years * AMA ≥ 35 years]). Appendix A displays the joint distribution 
of the dependent variables and independent variables by providing the frequency data and 
corresponding percentage in each matrix. The frequency data that reflect statistical significance 




 This section describes the results of the three dependent variables: (1) Down syndrome, 
(2) cleft lip with or without cleft palate, and (3) spina bifida.  
Results—Down Syndrome and Paternal Ages 
 I test the link between advanced paternal ages and Down syndrome using varying 
combinations of advanced paternal ages and advanced maternal age. Table 3 reports the results 
of my analyses for each relationship. In Table 3, Models 1 – 4 report the odds ratios derived from 
each logistic regression analysis. I hypothesized that advanced paternal ages increase the 
likelihood of Down syndrome. Accordingly, I summarize my hypotheses on the link between 
Down syndrome and advanced paternal ages and provide the analyses of my results: 
Hypothesis 1 and Analysis: 
Model I: Advanced reproductive aging in both father (paternal age 35+) and mother (maternal 
age 35+) are more likely to have a newborn with Down Syndrome than both parents with non-
advanced reproductive aging: The effects of both advanced parental ages are consistent with my 
expectations and are statistically significant. Hassold et al. (1996) and Thompson (2019) 
suggested that scientific studies need to include the father’s advanced age in the potential 
causation of Down syndrome since the lack of evidence on this relationship is unclear. My 
findings suggest that there is a 38% more likelihood of a father age 35+ (APA ≥ 35 years) to 
have a confirmed Down syndrome case in his newborn. While this is a modest research, it does 
offer some promising information to further investigate the link between APA and Down 
syndrome (Hassold et al, 1996; Thompson, 2019).  
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Model II: The interaction between the advanced reproductive aging in both father (paternal age 
35+) and mother (maternal age 35+) are more likely to have a newborn with Down Syndrome 
than both parents with non-advanced reproductive aging: The coefficient of the interaction 
variable yielded an opposite effect than predicted and is not statistically significant. However, 
the advanced paternal age (APA ≥ 35 years) as a separate variable in Model II is significant and 
suggests a 43% more likelihood of having a newborn with Down syndrome among fathers ages 
35+.  
Model III: Advanced reproductive aging in both father (paternal age 50+) and mother (maternal 
age 35+) are more likely to have a newborn with Down Syndrome than both parents with non-
advanced reproductive aging: The effects of that father age 50+ and mother age 35+ are 
consistent with my hypothesis and are statistically significant. The advanced paternal age (APA 
≥ 50 years) is significant and suggests a 60% more likelihood of having a newborn with Down 
syndrome among fathers ages 50+. 
Model IV: The interaction between the advanced reproductive aging in both father (paternal age 
50+) and mother (maternal age 35+) are more likely to have a newborn with Down Syndrome 
than both parents with non-advanced reproductive aging: The interaction effect of both advanced 
parental ages here are not consistent with my expectations and are not statistically significant. 
But in this model, only the maternal age 35+ was consistent with my expectations and 
statistically significant. Table 2 displays the predicted probabilities19 of the models that produced 
statistically significant results: 
 
 
19 Predicted probabilities are the probability or likelihood of an event (i.e., Down syndrome, cleft lip with or 
without cleft palate, and spina bifida) that is calculated from the available data (StataCorp., 2021) 
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Table 2: Predicted Probabilities of Down Syndrome 
Main Independent Variables Model 
          
  I II III IV 
Paternal Age ≥ 35 years = 0 0.0005*** 0.0050***     
Paternal Age ≥ 35 years = 1 0.0004*** 0.0004***     
          
Paternal Age ≥ 50 years = 0     0.0005*** 0.0005*** 
Paternal Age ≥ 50 years = 1     0.0006*** 0.0005*** 
          
Confidence Level Notes: *p<0.1; **p<0.05; ***p<0.01 
  
Results—Down Syndrome and Control Variables 
 In all four models in Table 3, tobacco use during pregnancy is not statistically significant 
and thus has no effect on Down syndrome20 in newborns. However, gestational diabetes is 
consistent with my expectations and is statistically significant in all four models. 
 
20 United States Department of Health and Human Services (US DHHS), Centers for Disease Control and 
Prevention” "(CDC), National Center for Health Statistics (NCHS), Division of Vital Statistics, Natality public-use data 
2016-2019, on CDC" WONDER Online Database, October 2020. Accessed at http://wonder.cdc.gov/natality-
expanded-current.html  on Jun 6, 2021, 1:24:47 PM." 
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Table 3: Relationship between Down Syndrome and Advanced Paternal Ages 
Table 3:  Relationship between Down Syndrome and Advanced Paternal Ages 
            
  Dependent variable: Down Syndrome 
      
  All Advanced Parental Ages 
    (I) (II) (III) (IV) 
Advanced Paternal Age 35+  1.382*** 1.433***   
  (0.126) (0.176)   
Advanced Maternal Age 35+  4.594*** 4.818*** 5.487*** 5.499*** 
   (0.416) (0.672) (0.397) (0.401) 
Advanced Parental Ages 35+  0.923   
   (0.167)   
Advanced Paternal Age 50+    1.599*** 1.791 
     (0.283) (0.901) 
Advanced Parental Ages      0.880 
Father 50+, Mother 35+     (0.473) 
Tobacco Use  1.258 1.256 1.236 2.714 
   (0.207) (0.207) 0.203 (1.388) 
Gestational Diabetes  1.307** 1.306** 1.312** 0.470** 
  (0.144) (0.144) (0.145) (0.237) 
Constant  0.000*** 0.000*** 0.000*** 0.000*** 
   (7.010) (7.390) (6.920) (6.950) 
Observations  3,295,210 3,295,210 3,295,210 3,295,210 
Likelihood Ratio   595.85*** 596.04*** 589.39*** 589.44*** 
Pseudo-R2   0.040 0.040 0.039 0.039 
Notes:  Values in parentheses are Standard Error (SE); *p<0.1; **p<0.05; ***p<0.01 
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Results—Cleft Lip with or without Cleft Palate and Paternal Ages 
I test the link between advanced paternal ages and Cleft Lip with or without Cleft Palate21 
using varying combinations of advanced paternal ages and advanced maternal age. Table 5 
displays the findings of my analyses for each relationship. In Table 5, Models 5 – 8 report the 
odds ratios derived from each logistic regression analysis. I hypothesized that APA increases the 
likelihood of cleft lip with or without cleft palate in newborns. Accordingly, I summarize my 
hypotheses on the link between cleft lip with or without cleft palate and advanced paternal ages 
and provide the analyses of my results: 
Hypothesis 2 and Analysis: 
Model V: Advanced reproductive aging in both father (paternal age 35+) and mother (maternal 
age 35+) are more likely to have a newborn with cleft lip with or without cleft palate than both 
parents with non-advanced reproductive aging: Surprisingly, I found a negative effect of paternal 
age 35+, which was statistically significant, on cleft lip with or without cleft palate. Consistent 
with the results found in the studies conducted by McIntosh et al. (1995) and Kazaura et al. 
(2004), they suggest that younger fathers have a higher likelihood of having newborns with 
neural tube defects like cleft lip. My findings suggests that fathers over 35 are about 15% less 
likely to have a child with cleft lip than fathers who are under 35 years of age. Since cleft lip has 
multifactorial influences, it is reasonable to argue that younger fathers (below 35 years) are more 
likely to be exposed to environmental and nutritional agents, for example, that may negatively 
 
21 United States Department of Health and Human Services (US DHHS), Centers for Disease  
Control and Prevention" "(CDC), National Center for Health Statistics (NCHS), Division of Vital Statistics, Natality 
public-use data 2016-2019, on CDC" "WONDER Online Database, October 2020. Accessed at 
http://wonder.cdc.gov/natality-expanded-current.html   on Jun 6, 2021, 1:29:36 PM.” 
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interact with inherent genetic mutations leading to birth defects (Lobo and Zhaurova, 2008). I 
found no support that maternal age 35+ increases the likelihood of cleft lip.  
Model VI: The interaction between the advanced reproductive aging in both father (paternal age 
35+) and mother (maternal age 35+) are more likely to have a newborn with cleft lip with or 
without cleft palate than both parents with non-advanced reproductive aging: I found no support 
that the interaction of both advance paternal ages (APA ≥ 35 years * AMA ≥ 35 years) increases 
the likelihood of cleft lip. But like Model V, I found statistical significance and a negative 
relationship between cleft lip and APA ≥ 35 years, suggesting a 15% less likelihood of cleft lip 
in newborns whose father’s age is 35+ years. Also, I found no support that maternal age 35+ 
increases the likelihood of cleft lip. 
Model VII: Advanced reproductive aging in both father (paternal age 50+) and mother (maternal 
age 35+) are more likely to have a newborn with cleft lip with or without cleft palate than both 
parents with non-advanced reproductive aging: While I did not find a relationship between cleft 
lip and paternal age 50+, I found a negative relationship between cleft lip with or without cleft 
palate and maternal age 35+ with statistically significant results. Essentially, the findings suggest 
that mothers 35+ years and older have a 14% less likelihood to have a child with cleft lip than 
mothers who are younger than 35 years of age.   
Model VIII: The interaction between the advanced reproductive aging in both father (paternal 
age 50+) and mother (maternal age 35+) are more likely to have a newborn with cleft lip with or 
without cleft palate than both parents with non-advanced reproductive aging: The interaction 
effect of both advanced parental ages in Model VIII are not consistent with my expectations and 
are not statistically significant. But I found a negative relationship between cleft lip with or 
without cleft palate and maternal age 35+ with statistically significant results. This suggests that 
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mothers 35+ years and older have a 14% less likelihood to have a child with cleft lip than 
mothers who are below the age of 35 years.   
Table 4 displays the predicted probabilities of the models that produced statistically significant 
results:  
Table 4: Predicted Probabilities of Cleft Lip with or without Cleft Palate 
Main Independent Variables Model 
          
  V VI VII VIII 
Paternal Age ≥ 35 years = 0 0.0002*** 0.0002***     
Paternal Age ≥ 35 years = 1 0.0028*** 0.0003***     
          
Paternal Age ≥ 50 years = 0     0.0002*** 0.0002*** 
Paternal Age ≥ 50 years = 1     0.0004*** 0.0004*** 
          
Confidence Level Notes: *p<0.1; **p<0.05; ***p<0.01 
 
Results—Cleft Lip with or without Cleft Palate and Control Variables  
In all four models in Table 5, tobacco use during pregnancy and gestational diabetes are 
consistent with my expectations and are statistically significant. This suggests that tobacco use 
during pregnancy and gestational diabetes increase the likelihood of cleft lip with or without cleft 
palate in newborns.  
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Table 5: Relationship between Cleft Lip and Advanced Paternal Ages  
Table 5:  Relationship between Cleft Lip with or without Cleft Palate 
and Advanced Paternal Ages 
    
  Dependent variable: Cleft Lip with or without Cleft Palate 
      
  All Advanced Parental Ages 
    (V) (VI) (VII) (VIII) 
Advanced Paternal Age 35+  0.847** 0.851**   
  (0.055) (0.062)   
Advanced Maternal Age 35+  0.970 0.987 0.869** 0.868** 
   (0.075) (0.134) (0.058) (0.059) 
Advanced Parental Ages 35+   0.974   
   (0.161)   
Advanced Paternal Age 50+      1.190 1.152 
       (0.247) (0.366) 
Advanced Parental Ages      1.058 
Father 50+, Mother 35+     (0.444) 
Tobacco Use  1.504*** 1.503*** 1.503*** 1.503*** 
   (0.149) (0.149) (0.149) (0.149) 
Gestational Diabetes  1.218** 1.218** 1.209** 1.209** 
  (0.111) (0.111) (0.110) (0.110) 
Constant  0.000*** 0.000*** 0.000*** 0.000*** 
   (0.000) (0.000) (0.000) (0.000) 
Observations  3,296,177 3,296,177 3,296,177 3,296,177 
Likelihood Ratio  30.16*** 30.19*** 24.20*** 24.22*** 
Pseudo-R2   0.001 0.001 0.001 0.001 




Results—Spina Bifida and Advanced Paternal Ages 
 I test the relationship between advanced paternal ages and Spina Bifida22 while 
employing different dimensions of the father’s advanced age. Table 7 displays the findings of my 
analyses for the relationship between spina bifida and (a) APA ≥ 35 years and AMA ≥ 35 years; 
(b) APA ≥ 35 years and AMA ≥ 35 years, and the interaction between APA ≥ 35 years * AMA ≥ 
35 years; (c) APA ≥ 50 years and AMA ≥ 35 years; and (d) APA ≥ 50 years and AMA ≥ 35 
years, and the interaction between APA ≥ 50 years * AMA ≥ 35 years. Accordingly, I 
summarize my hypotheses on the link between spina bifida and advanced paternal ages and 
provide the analyses of my results: 
Hypothesis 3 and Analysis: 
Model IX: Advanced reproductive aging in both father (paternal age 35+) and mother (maternal 
age 35+) are more likely to have a newborn with spina bifida than both parents with non-
advanced reproductive aging: The advanced paternal age (APA ≥ 35 years) has a negative effect 
but is not statistically significant. Whereas the advanced maternal age (AMA ≥ 35 years) has a 
positive effect but is not statistically significant. Although spina bifida is classified as a genetic 
birth abnormality, this birth defect manifests from the interaction of genetic mutations and 
environmental (or multifactorial) influences (Lobo and Zhaurova, 2008). There are numerous 
multifactorial influences (e.g., the combination of each parent’s environment, daily diet, 
nutritional deficiencies, maternal infections, consumption of alcohol, drugs, and/or tobacco use, 
etc.) that become confounding variables in this type of genetic disease (Berkow et al., 1997). 
 
22 United States Department of Health and Human Services (US DHHS), Centers for Disease Control and 
Prevention""(CDC), National Center for Health Statistics (NCHS), Division of Vital Statistics, Natality public-use data 
2016-2019, on CDC" "WONDER Online Database, October 2020. Accessed at http://wonder.cdc.gov/natality-
expanded-current.html  on Jun 6, 2021, 1:07:36 PM." 
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Thus, it is difficult to produce definitive results when genetic diseases that have multifactorial 
influences.     
Model X: The interaction between the advanced reproductive aging in both father (paternal age 
35+) and mother (maternal age 35+) are more likely to have a newborn with spina bifida than 
both parents with non-advanced reproductive aging: Similar to Model IX, Model X yielded 
similar findings that do not support my predictions. Thus, the inclusion of the interaction variable 
is not significant for the relationship between spina bifida and the explanatory variable (i.e., 
advanced paternal age [APA ≥ 35 years]).  
Model XI: Advanced reproductive aging in both father (paternal age 50+) and mother (maternal 
age 35+) are more likely to have a newborn with spina bifida than both parents with non-
advanced reproductive aging: These explanatory variables do not affect the probability of spina 
bifida and do not reflect statistical significance.  
Model XII: The interaction between the advanced reproductive aging in both father (paternal 
age 50+) and mother (maternal age 35+) are more likely to have a newborn with spina bifida 
than both parents with non-advanced reproductive aging: The interaction variable of paternal age 










Table 6: Predicted Probabilities of Spina Bifida 
Main Independent Variables Model 
  IX X XI XII 
Paternal Age ≥ 35 years = 0 0.0001*** 0.0001***     
Paternal Age ≥ 35 years = 1 0.0001*** 0.0001***     
          
Paternal Age ≥ 50 years = 0     0.0001***       0.0001*** 
Paternal Age ≥ 50 years = 1     0.0001** 0.0001 
          
Confidence Level Notes: *p<0.1; **p<0.05; ***p<0.01 
 
Results—Spina Bifida and Control Variables  
In all four models in Table 7, tobacco use during pregnancy and gestational diabetes are 
consistent with my expectations and are statistically significant. This suggests that tobacco use 
during pregnancy and gestational diabetes increase the likelihood of spina bifida in newborns. 
The combination of genetic and environmental agents suggests that spina bifida has 
multifactorial influences as supported by this study (Conti and Eisenberg, 2016). Tobacco use 
during pregnancy and gestational diabetes are classified as confounding variables (i.e., 
environmental and nutritional agents) that may influence the reproduction stage, resulting in the 










Table 7: Relationship between Spina Bifida and Advanced Paternal Ages 
Table 7:  Relationship between Spina Bifida and Advanced Paternal Ages 
     
  Dependent variable: Spina Bifida 
      
  All Advanced Parental Ages 
    (IX) (X) (XI) (XII) 
Advanced Paternal Age 35+  0.882 0.819   
  (0.106) (0.114)   
Advanced Maternal Age 35+  1.165 0.912 1.086 1.074 
   (0.159) (0.242) (0.126) (0.126) 
Advanced Parental Ages 35+   1.424   
   (0.446)   
Advanced Paternal Age 50+    0.766 0.410 
     (0.346) (0.411) 
Advanced Parental Ages      2.400 
Father 50+, Mother 35+     (2.698) 
Tobacco Use  1.423* 1.429* 1.427* 1.429* 
   (0.269) (0.270) 0.270 (0.270) 
Gestational Diabetes  1.515*** 1.518*** 1.508*** 1.508*** 
  (0.232) (0.233) 0.231 (0.231) 
Constant  0.000*** 0.000*** 0.000*** 0.000*** 
   (7.930) (8.180) (7.280) (7.300) 
    0 0 0 0 
Observations  3,296,177 3,296,177 3,296,177 3,296,177 
Likelihood Ratio  11.37** 12.71** 10.630** 11.340** 
Pseudo-R2   0.001 0.001 0.001 0.001 





 Does advanced paternal ages affect the likelihood of genetic diseases and congenital 
anomalies in newborns? This thesis seeks to fully appreciate whether advanced paternal ages 
may, too, contribute to birth defects in infants. Limited studies have investigated the link 
between advanced paternal age and genetic disease and congenital anomalies systematically 
(Thompson, 2019). The extent of the study on the relationship between advanced age and 
reproductive anomalies rely mainly on AMA, while the possible link between APA and 
reproductive anomalies has been recently reviewed (Halvaei et al., 2020). Thus, this thesis 
conducts a study to analyze the link between advanced paternal ages and genetic diseases and 
congenital anomalies to shed light on the topic. This study’s findings confirm a positive 
relationship between advanced paternal ages (APA ≥ 35 years and APA ≥ 50 years) and Down 
syndrome. Fathers 35+ and 50+ are associated with a higher likelihood of having a newborn with 
Down syndrome. Essentially, these findings suggest an elevation in the risk for advanced 
paternal ages and the manifestation of Down syndrome. Considering these outcomes, future 
studies may be able to analyze these predictions by including more recent observations (e.g., 
2020 – 2023) to reinforce the scientific relationship between APA and Down syndrome.  
Interestingly, findings confirm a negative relationship between advanced paternal age 
(APA ≥ 35 years) and cleft lip with or without cleft palate, which suggests that a father who is 
younger than age 35 years has a higher likelihood of having a newborn with cleft lip with or 
without cleft palate. These results are consistent with McIntosh et al. (1995) and Kazaura et al. 
(2004) who suggest a negative effect of APA and NTDs such as cleft lip.  
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 Is paternal age just a number when it comes to reproductive anomalies? This study 
provides some explanation to the literature by exploring the effect of advanced paternal ages on 
genetic diseases and congenital anomalies. My substantive results suggest a causal relationship 
between advanced paternal ages and Down syndrome, but the study finds no support for 
Hypotheses 2 and 3 (i.e., the relationship between advanced paternal ages and cleft lip and the 
relationship between advanced paternal ages and spina bifida). The literature provides important 
guidance in advancing the research on advanced paternal ages and genetic diseases and 
congenital anomalies. This study furthers Penrose’s (1955) copy error theory by distinctively 
examining the father’s advanced age in relation to birth defects by explicitly stating that when a 
father’s age is 35 and older, he may have an increased likelihood of having a newborn with 
genetic diseases and congenital anomalies. Considering the positive relationship found between 
Down syndrome and advanced paternal ages and the negative relationship between cleft lip and 
advanced paternal age (APA ≥ 35 years), this study may be helpful to potential studies in the 
areas of epidemiology and genetics. The implications in the results may motivate scholars to 
develop models by incorporating added confounding variables (e.g., socio-economic factors, 
father’s diet containing consumption of alcohol and/or drugs, etc.). Including more confounding 
variables is important in furthering our understanding on how the father’s age may affect the 
likelihood of reproductive anomalies. Based on the growing interest in analyzing the father’s age 
in studies on reproductive health, it may be useful for future studies to build on the empirical 





APPENDIX A:  SUMMARY STATISTICS23 
  
 
23 Collection of data for all variables used in this research are obtained with full permission from: United States 
Department of Health and Human Services (US DHHS), Centers for Disease Control and Prevention” "(CDC), 
National Center for Health Statistics (NCHS), Division of Vital Statistics, Natality public-use data 2016-2019, on 
CDC" WONDER Online Database, October 2020. Accessed at http://wonder.cdc.gov/natality-expanded-
current.html on Jun 6, 2021, 1:24:47 PM;" United States Department of Health and Human Services (US DHHS), 
Centers for Disease Control and Prevention" "(CDC), National Center for Health Statistics (NCHS), Division of Vital 
Statistics, Natality public-use data 2016-2019, on CDC" "WONDER Online Database, October 2020. Accessed at 
http://wonder.cdc.gov/natality-expanded-current.html on Jun 6, 2021, 1:29:36 PM;” And United States 
Department of Health and Human Services (US DHHS), Centers for Disease Control and Prevention""(CDC), 
National Center for Health Statistics (NCHS), Division of Vital Statistics, Natality public-use data 2016-2019, on 
CDC" "WONDER Online Database, October 2020. Accessed at http://wonder.cdc.gov/natality-expanded-





Summary Statistics – Down Syndrome 
Down Syndrome Father ≥ 35 years   Father ≥ 50 years 
No  Yes  No  Yes 
No 2,223,877 99.99%  1,070,525 99.95%  3,250,496 99.98%  43,906 99.92% 
Yes 313 0.01%  495 0.05%  774 0.02%  34 0.08% 
Total 2,224,190 100%  1,071,020 100%  3,251,270 100%  43,940 100% 
N=3,295,210 Pr= 0.000   Pr= 0.000 
            
Down Syndrome Mother ≥ 35 years   Both Parental Ages ≥ 35 years 
No  Yes  No  Yes 
No 2,647,487 99.99%  646,915 99.93%  2,760,605 99.99%  533,797 99.92% 
Yes 339 0.01%  694 0.07%  404 0.01%  404 0.08% 
Total 2,647,826 100%  2,647,826 100%  2,761,009 100%  534,201 100% 
N=3,295,210 Pr= 0.000   Pr= 0.000 
            
Down Syndrome Father ≥ 50 years * Mother≥ 35 years   
 No  Yes  
No 3,267,729 99.98%  26,673 99.89%  
 
Yes 778 0.02%  30 0.11%  
Total 3,268,507 100%  26,703 100%  
N=3,295,210 Pr= 0.000    
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Summary Statistics – Cleft Lip 
         
Cleft Lip Father ≥ 35 years   Father ≥ 50 years 
No  Yes  No  Yes 
No 2,223,524 99.95%  1,071,077 99.96%  3,250,642 99.95%  43,959 99.95% 
Yes 1,123 0.05%  453 0.04%  1,552 0.05%  24 0.05% 
Total 2,224,647 100%  1,071,530 100%  3,252,194 100%  43,983 100% 
N=3,296,177 Pr= 0.001   Pr= 0.514 
            
Cleft Lip Mother ≥ 35 years   Both Parental Ages ≥ 35 years 
No  Yes  No  Yes 
No 2,647,013 99.95%  647,588 99.96%  2,760,218 99.95%  534,383 99.06% 
Yes 1,298 0.05%  278 0.04%  1,355 0.05%  221 0.04% 
Total 2,648,311 100%  647,866 100%  2,761,573 100%  534,604 100% 
N=3,296,177 Pr= 0.044   Pr= 0.018 
            
Cleft Lip Father ≥ 50 years * Mother≥ 35 years    
No  Yes     
No 3,267,870 99.95%  26,731 99.95%       
Yes 1,562 0.05%  14 0.05%       
Total 3,269,432 100%  26,745 100%       







Summary Statistics – Spina Bifida 
 
Spina Bifida Father ≥ 35 years   Father ≥ 50 years 
No  Yes  No  Yes 
No 2,224,333 99.99%  1,071,385 99.99%  3,251,740 99.99%  43,978 99.99% 
Yes 314 0.01%  145 0.01%  454 0.01%  5 0.01% 
Total 2,224,647 100%  1,071,530 100%  3,252,194 100%  43,983 100% 
N=3,296,177 Pr= 0.675   Pr= 0.647 
            
Spina Bifida Mother ≥ 35 years   Both Parental Ages ≥ 35 years 
No  Yes  No  Yes 
No 2,647,949 99.99%  647,769 99.99%  2,761,196 99.99%  534,522 99.98% 
Yes 362 0.01%  97 0.01%  377 0.01%  82 0.02% 
Total 2,648,311 100%  647,866 100%  2,761,573 100%  534,604 100% 
N=3,296,177 Pr= 0.426   Pr= 0.339 
            
Spina Bifida Father ≥ 50 years * Mother≥ 35 years   
 
No  Yes  
No 3,268,977 99.99%  26,741 99.99%  
Yes 455 0.01%  4 0.01%  
Total 3,269,432 100%  26,745 100%  
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